Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from ENDRA Life Sciences ( (NDRA) ) is now available.
ENDRA Life Sciences Inc. has initiated a cryptocurrency treasury strategy, retaining Anchorage Digital Bank as a custodian and engaging Arca Investment Management to manage its cryptocurrency holdings. On July 23, 2025, the company formed a Cryptocurrency Advisory Board, appointing industry experts to guide its strategy, potentially impacting its financial operations and positioning in the market.
The most recent analyst rating on (NDRA) stock is a Buy with a $10.00 price target. To see the full list of analyst forecasts on ENDRA Life Sciences stock, see the NDRA Stock Forecast page.
Spark’s Take on NDRA Stock
According to Spark, TipRanks’ AI Analyst, NDRA is a Underperform.
ENDRA Life Sciences is currently facing significant financial and operational challenges, with no revenue generation and persistent losses. Despite some short-term technical momentum, the lack of profitability and unattractive valuation metrics weigh heavily on the stock’s potential. Immediate improvements in financial performance and strategic direction are crucial for enhancing its outlook.
To see Spark’s full report on NDRA stock, click here.
More about ENDRA Life Sciences
ENDRA Life Sciences Inc. operates in the life sciences industry, focusing on developing advanced technologies for medical imaging and diagnostics.
Average Trading Volume: 1,699,634
Technical Sentiment Signal: Sell
Current Market Cap: $4.89M
See more insights into NDRA stock on TipRanks’ Stock Analysis page.